Advertisement
Advertisement
U.S. markets open in 5 hours 7 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Stryker Corporation (SYK)

NYSE - NYSE Delayed Price. Currency in USD
243.11+2.34 (+0.97%)
At close: 04:04PM EST
236.00 -7.11 (-2.92%)
Pre-Market: 04:06AM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close240.77
Open237.81
Bid0.00 x 800
Ask0.00 x 900
Day's Range237.81 - 244.06
52 Week Range188.84 - 280.43
Volume1,192,116
Avg. Volume1,534,325
Market Cap92B
Beta (5Y Monthly)0.99
PE Ratio (TTM)37.81
EPS (TTM)6.43
Earnings DateJan 25, 2023 - Jan 30, 2023
Forward Dividend & Yield2.78 (1.14%)
Ex-Dividend DateSep 29, 2022
1y Target Est238.39
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-17% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for SYK

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Stryker Corporation
    Analyst Report: Stryker CorporationStryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and spinal devices. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Nearly one fourth of Stryker's total revenue currently comes from outside the United States.
    Rating
    Fair Value
    Economic Moat
    13 days agoMorningstar
View more
Advertisement
Advertisement